Trial Profile

An Open Label Study to Evaluate the Safety and Gastric-Retentive Properties of Modified Release Capsules Containing Memantine Hydrochloride in Healthy Adults

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 16 Jul 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Memantine (Primary)
Indications Alzheimer's disease
Focus Adverse reactions; Pharmacokinetics
Sponsors Lyndra

Most Recent Events

25 Feb 2019 Status changed from active, no longer recruiting to completed.
15 Nov 2018 Preliminary Results presented in the Lyndra Therapeutics media release.
16 Oct 2018 Status changed to active, no longer recruiting.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com